Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Response Trial of Biosynthetic Authentic Human Growth Hormone and Induction of Puberty With 17b Oestradiol in Girls With Turner's Syndrome

NCT01518062 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01518062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01518062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Response Trial of Biosynthetic Authentic Human Growth Hormone and Induction of Puberty With 17b Oestradiol in Girls With Turner's Syndrome
Lead sponsor
Novo Nordisk A/S
Phase
Phase 4
Overall status
Completed
Start date
November 30, 1989
Completion date
September 30, 2003
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic disorder, turner syndrome